This post was originally published on this site
Medtronic announced earnings per share of $1.41 on revenue of $7.99B. Analysts polled by Investing.com anticipated EPS of $1.32 on revenue of $7.87B.
Medtronic shares are up 9% from the beginning of the year, still down 2.95% from its 52 week high of $132.39 set on August 2. They are under-performing the S&P 500 which is up 19.26% from the start of the year.
Medtronic’s report follows an earnings beat by Pfizer on July 28, who reported EPS of $1.07 on revenue of $18.98B, compared to forecasts EPS of $0.9705 on revenue of $18.71B.
Novo Nordisk ADR had beat expectations on August 4 with second quarter EPS of $0.8379 on revenue of $5.26B, compared to forecast for EPS of $0.7823 on revenue of $5.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
